Continuing Medical Education


Dana-Farber Cancer Institute, a principal teaching affiliate of Harvard Medical School, shares advances in cancer research and treatment with the healthcare community through continuing medical education (CME) courses.

Dana-Farber CME courses, offered in conjunction with Harvard Medical School or Partners HealthCare Office of Continuing Professional Development, which are both accredited by the Accreditation Council for Continuing Medical Education (ACCME), provide continuing medical education for physicians. These educational activities have been designated as credit towards the AMA Physician's Recognition Award.

Upcoming Courses

4th Annual Update in Neuro-Oncology
July 24-26, 2024
This three-day CME course, Annual Update in Neuro-Oncology, is designed to provide an international audience with a comprehensive review of the diagnosis and management of pediatric and adult patients with primary and metastatic CNS and PNS tumors and neurological complications of cancer.

View course and register

Stem Cell Transplant and Cellular Therapies Symposium: Optimizing Collaborative Care
October 18, 2024
Course Format: In Person and Live Virtual
This program aims to fill the gap in knowledge that community health care professionals may have in caring for patients who receive stem cell transplants or CAR T-cell therapy.

View course and register

Grand Rounds

Dana-Farber is a teaching affiliate of Harvard Medical School and founder of Dana-Farber/Harvard Cancer Center, a Comprehensive Cancer Center designated by the National Cancer Institute.

Visit our calendar of on-site educational opportunities for healthcare professionals, researchers and scientists, available through Dana-Farber and partnering institutions.